3D Medicines Inc.

HK$2.60As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1244Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 4Y CAGR (51.53%)
Div yield —
ROE (32.79%)
Biotechnology
Beta (5Y) 0.15
PE TTM —
TSR TTM (58.72%)
Mkt cap HK$640.6M
ROIC (15.97%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.98
14.51%
(88.95%)
Hold 0|10|11|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.04
0.04
0.04
0.05
37.66%
35.86%
43.00%
41.01%
Revenue¥M
28.21
29.87
31.52
31.22
1.05%
5.48%
11.66%
12.80%
Peers (US$81.72M)
Cap (US$)
PE
59.29M
—
82.04M
—
Capital
TTM
5Y
10Y
Leveragex
0.929
0.208
0.182
EBIT/Intx
3.482
0.105
0.094
Own earn%
44.53
(70.33)
(80.03)
Sh yield%
40.74
37.45
38.57
Owners
Insiders/Inst%
11.41
24.25
Short interest%
4.16
SBC / revenue%
4.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
5–10
$1 testx
—
Incr. ROIC%
13